Jeffrey Ubben
ValueAct Holdings
Jeffrey Ubben Bausch Health Companies Inc stake
total: 107
ValueAct Holdings BHC trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 4
- Held since:
- 2018 Q3
- Held for:
- 16 quarters
- Latest activity:
- 2022 Q3
According to 2026 Q2 report, Jeffrey Ubben doesn't hold any Bausch Health Companies Inc (BHC) shares. To date, the estimated cost basis is nearly $25.67 for "buy" trades and estimated average "sell" price is $11.89. ValueAct Holdings first purchased BHC in 2018 Q3, initially acquiring about 18.03M shares. Since the initial investment in Bausch Health Companies Inc (BHC), ValueAct Holdings has made 6 more transactions.
When did Jeffrey Ubben sell Bausch Health Companies Inc (BHC)?
Jeffrey Ubben sold off the entire Bausch Health Companies Inc (BHC) position in 2022 Q3.
When did Jeffrey Ubben buy Bausch Health Companies Inc (BHC)?
Jeffrey Ubben first invested in Bausch Health Companies Inc (BHC) in 2018 Q3 at the reported quarter-end price of $25.67 per share.
What's the cost basis of ValueAct Holdings's BHC stake?
The estimated cost basis for Bausch Health Companies Inc (BHC) stake is around $25.67 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $25.67
- Weighted AVG sell price:
- $11.89
Jeffrey Ubben's historical trades in Bausch Health Companies Inc
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q3
|
0.00%
|
0
|
$8.36
|
|
-100% (-14,341,265)
|
-1.91%
|
|
2022 Q2
|
1.91%
|
14,341,265
|
$8.36
|
$119,893,000
|
-0.62% (-89,636)
|
-0.01%
|
|
2022 Q1
|
4.54%
|
14,430,901
|
$22.85
|
$329,746,000
|
-7.59% (-1,185,860)
|
-0.31%
|
|
2021 Q4
|
4.86%
|
15,616,761
|
$27.61
|
$431,179,000
|
-12.96% (-2,324,842)
|
-0.74%
|
|
2020 Q4
|
4.33%
|
$20.80
|
+0.06% (+10,009)
|
|||
|
2019 Q2
|
4.72%
|
$25.22
|
-0.56% (-101,555)
|
|||
|
2018 Q3
|
4.55%
|
$25.67
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.